Responsible for analytical method development, validation, verification, routine testing, XRD and feasibility studies, preparation of protocols and reports, laboratory compliance, safety adherence, documentation management, incident reporting, training completion, and maintaining continuous audit readiness in the Analytical Development Laboratory.
Technical:
Support:

Endo combined with Mallinckrodt Pharmaceuticals in 2025 to better serve customers and improve outcomes for the patients we support.
From this union, we established two focused, standalone companies:
– Keenova Therapeutics, a branded therapeutics business
– Par Health, a generics and sterile injectables business
To learn more, follow Keenova and Par Health on LinkedIn and visit keenova.com and parhealth.com.